NCT03510624View on ClinicalTrials.gov

Acute Effect of Rebaudioside A on Glucose Excursion During an Oral Glucose Tolerance Test in Type 2 Diabetes Mellitus

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 9, 2018

Primary Completion Date

April 1, 2021

Study Completion Date

April 1, 2021

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

Rebaudioside A

Rebaudioside A 3g

DRUG

Placebo

Empty capsules

Trial Locations (1)

3000

Centrum Clinical Pharmacology, Leuven

All Listed Sponsors
lead

Universitaire Ziekenhuizen KU Leuven

OTHER

NCT03510624 - Acute Effect of Rebaudioside A on Glucose Excursion During an Oral Glucose Tolerance Test in Type 2 Diabetes Mellitus | Biotech Hunter | Biotech Hunter